Lyell Immunopharma EPS LYEL

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Lyell Immunopharma's earnings per share was −$12.02 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$1.92.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$1.92	n/a	−$12.02
Q1 FY26	Mar 31, 2026	−$1.10	n/a	−$12.99
Q4 FY25	Dec 31, 2025	−$6.87	n/a	−$15.43
Q3 FY25	Sep 30, 2025	−$2.13	n/a	−$22.28
Q2 FY25	Jun 30, 2025	−$2.89	n/a	−$23.63
Q1 FY25	Mar 31, 2025	−$3.54	n/a	−$24.33
Q4 FY24	Dec 31, 2024	−$13.72	n/a	−$25.59
Q3 FY24	Sep 30, 2024	−$3.48	n/a	−$16.07
Q2 FY24	Jun 30, 2024	−$3.59	n/a	−$16.59
Q1 FY24	Mar 31, 2024	−$4.80	n/a	−$18.20
Q4 FY23	Dec 31, 2023	−$4.20	n/a	−$18.80
Q3 FY23	Sep 30, 2023	−$4.00	n/a	−$15.20

Companies in Drug Manufacturers - General nearest Lyell Immunopharma's size, closest first, today.

Company	EPS, 12 months	Growth
LYELLyell Immunopharma	−$12.02
NATRNatures Sunshine Products	$1.01	+36% a year
ARVNArvinas	$0.16
PBYIPuma Biotechnology	$0.52	−47% a year
IRWDIronwood Pharmaceuticals	$0.77
ZVRAZevra Therapeutics	$0.93
CRMDCorMedix	$2.13	+184% a year
LFVNLifevantage	$0.40	−46% a year
COLLCollegium Pharmaceutical	$1.24	+19% a year
SPROSpero Therapeutics	$0.11
ABUSArbutus Biopharma	$0.78
Peer median	$0.78